Infinity Pharmaceuticals, Inc.
Infinity Pharmaceuticals, Inc. (INFIQ) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · INFIQ · as of Jun 8, 2026
Key Statistics
Explore Infinity Pharmaceuticals, Inc. Data
infiq stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 14 · Buy rate: 35.7%
Competitors & Peers
infiq competitorsINFIQ
AFIB
ARDS
BTAX
EVLO
HSTCStock Performance
Full HistoryAbout Infinity Pharmaceuticals, Inc.
Infinity Pharmaceuticals, Inc. a clinical-stage biopharmaceutical company, focuses on developing novel medicines for people with cancer. The company's product candidate, including eganelisib (IPI-549…
what is infinity pharmaceuticals, inc. · infiq stock overview · infinity pharmaceuticals, inc. company profile · who is infinity pharmaceuticals, inc. ceo · infiq OTC · infinity pharmaceuticals, inc. headquarters · infinity pharmaceuticals, inc. business segments
About Stock Overview & Key Data
Infinity Pharmaceuticals, Inc. (INFIQ) is a Healthcare company in the Biotechnology industry, listed on OTC since Jul 27, 2000. As of the latest trading session, INFIQ stock price is $0.00, with a market capitalization of $9,076. The stock has returned +9900.00% over the past 12 months and +0.00% year-to-date.
According to 14 Wall Street analysts, the consensus rating for Infinity Pharmaceuticals, Inc. stock is Hold, with an average 12-month price target of $—. In fiscal year 2022, Infinity Pharmaceuticals, Inc. reported revenue of $2.6M and net income of -$44.4M. For detailed data — including Infinity Pharmaceuticals, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Infinity Pharmaceuticals, Inc. (INFIQ) stock price is $0.00. The stock is traded on OTC under the ticker symbol INFIQ. The 52-week range is $0.00 – $0.00.